XML 28 R18.htm IDEA: XBRL DOCUMENT v3.19.2
Equity and Equity Incentive Plan
3 Months Ended
Mar. 31, 2019
Share-based Payment Arrangement [Abstract]  
Equity and Equity Incentive Plan

13. EQUITY AND EQUITY INCENTIVE PLAN

 

Common Stock

 

The Company had 218,119,561 and 161,086,228 common shares outstanding at March 31, 2019 and December 31, 2018, respectively.

 

In December 2018, the Company issued 20,000,000 shares of common stock to our CEO as an incentive bonus. As the shares are subject to continued employment by the CEO through January 2, 2020, the Company has treated the shares as issued but not as yet outstanding. Expense for the issuance is being recognized over the full vesting period, and accordingly, the Company recognized stock compensation expense of $10,576 as of December 31, 2018. During the three months ended March 31, 2019 the Company recognized additional stock compensation expense of $45,876. The Total amount of expense recorded as of March 31, 2019 is $56,452.

 

On August 1, 2017, Mr. Mikkel Pitzner was appointed by the Company’s board of directors to serve on the Company’s board of directors, filling a vacancy on the board. Mr. Pitzner shall serve on the board of directors and shall hold office until the next election of directors by stockholders and until his successor is elected and qualified or until his earlier resignation or removal. The Company has agreed to pay Mr. Pitzner an annual fee of $6,000 and has issued Mr. Pitzner 3,333,333 shares of restricted common stock valued at $31,250 under a consulting agreement expiring in January 2019. In December 2018, Mr. Pitzner was issued 708,287 common shares in payment of accrued director fees through December 31, 2018. The shares were valued at $0.0195 per share, totaling $13,812, the fair value on the date of grant. During the three months ended March 31, 2019 the Company recorded $31,275 of stock compensation pursuant to this agreement.

  

In January 2019, the Company entered into an investment banking and corporate advisory agreement. The term of the agreement is for one year and provided for compensation of 2,700,000 common shares with a fair value of $29,700 plus related expenses. The shares were issued in February and March 2019. For the three months ended March 31, 2019 the Company expenses $7,400 in stock compensation.

 

In January 2019, the Company issued 1,000,000 common shares with a fair value of $12,500 to a consultant for general administrative advisory services, of which $7,500 was expensed during the three months ended March 31, 2019.

 

In March, 2019 we issued an accredited investor, a unit of the securities of the Company, with the unit consisting of 50,000,000 shares of common stock, par value $0.0001 per share and 50,000,000 eighteen month common stock purchase warrants exercisable at $0.01 per share in consideration of $500,000. The Company intends to use the proceeds from the sale for product research and development and working capital purposes. The Company did not pay any fees or commissions in connection with the sale of the unit.

 

Preferred Stock

 

During the second quarter of 2010, the holder of the majority of the Company’s outstanding shares of common stock approved an amendment to the Company’s Articles of Incorporation authorizing the issuance of 10,000,000 shares of preferred stock. The preferred stock as authorized has such voting powers, designations, preferences, limitations, restrictions and relative rights as may be determined by our Board of Directors of the Company from time to time in accordance with the provisions of the Florida Business Corporation Act. Before modification, the existing Articles of Incorporation did not authorize the issuance of shares of preferred stock. The Company authorized the preferred stock for the purpose of added flexibility in seeking capital and potential acquisition targets. The amendment authorizing the issuance of shares of preferred stock grants the Board authority, without further action by our stockholders, to designate and issue preferred stock in one or more series and to designate certain rights, preferences and restrictions of each series, any or all of which may be greater than the rights of the common stock. As of March 31, 2019 and December 31, 2018, the 425,000 shares of preferred stock are owned by the Company’s Chief Executive Officer. The preferred shares have 250 to 1 voting rights over the common stock, and are convertible into 31,481 shares of common stock. The preferred stock votes with the Company’s common stock, except as otherwise required under Florida law.

 

Equity Incentive Plan

 

On August 22, 2007, the Company adopted an Equity Incentive Plan (the “Plan”). The Plan expired on August 22, 2017. All 297 options issued under the Plan had expired as of March 31, 2019.

  

Equity Compensation Plan Information as of December 31, 2018.

 

    Number of securities
to be issued upon exercise of outstanding options, warrants and rights (a)
    Weighted – average exercise price of outstanding options, warrants and rights (b)     Number of securities remaining available for future issuances under equity compensation plans (excluding securities reflected in column (a) (c)  
Equity Compensation Plans Approved by Security Holders     297     $ 1,350        
Equity Compensation Plans Not Approved by Security Holders                  
Total     297     $ 1,350        

 

Equity Compensation Plan Information as of March 31, 2019.

 

      Number of securities
to be issued upon exercise of outstanding options, warrants and rights (a)
      Weighted – average exercise price of outstanding options, warrants and rights (b)       Number of securities remaining available for future issuances under equity compensation plans (excluding securities reflected in column (a) (c)  
Equity Compensation Plans Approved by Security Holders         $        
Equity Compensation Plans Not Approved by Security Holders                  
Total         $